Form 4 Filing for Artiva Biotherapeutics, Inc.

This filing details a transaction by Banerjee Subhashis, Chief Medical Officer of Artiva Biotherapeutics, Inc. On May 19, 2026, 7,037 shares of common stock were disposed of under a 'sell-to-cover' policy to satisfy tax withholding obligations related to the vesting of restricted stock units. These sales were automatic and not at the discretion of the reporting person. The weighted average sale price was $9.0076, with prices ranging from $8.7404 to $9.0104. Following this transaction, the reporting person owns 144,963 shares.